WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2024 Poal.co

963

And nothing could possibly go wrong /s. Really, it is a interesting thought but despite their ideas and intent I am not sure I really get the need.

Then again, if they are successful the environmentalists can fuck off forever since we can just "de-extinct" a creature if it is useful to the environment.

Archive: https://archive.today/feGEj

From the post:

>Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the scientific breakthroughs toward "de-extinction," or bringing back extinct species like the woolly mammoth, thylacine and the dodo. [...] Since launching in September 2021, Colossal has raised $435 million in total funding. This latest round of capital places the company at a $10.2 billion valuation. Colossal will leverage this latest infusion of capital to continue to advance its genetic engineering technologies while pioneering new revolutionary software, wetware and hardware solutions, which have applications beyond de-extinction including species preservation and human healthcare.

And nothing could possibly go wrong /s. Really, it is a interesting thought but despite their ideas and intent I am not sure I really get the need. Then again, if they are successful the environmentalists can fuck off forever since we can just "de-extinct" a creature if it is useful to the environment. Archive: https://archive.today/feGEj From the post: >>Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the scientific breakthroughs toward "de-extinction," or bringing back extinct species like the woolly mammoth, thylacine and the dodo. [...] Since launching in September 2021, Colossal has raised $435 million in total funding. This latest round of capital places the company at a $10.2 billion valuation. Colossal will leverage this latest infusion of capital to continue to advance its genetic engineering technologies while pioneering new revolutionary software, wetware and hardware solutions, which have applications beyond de-extinction including species preservation and human healthcare.

Be the first to comment!